🔗 Permalink

Inventor profile of:

Mark E. Gurney

City:

Grand Rapids, Michigan

Country:

United States

Published Applications:

Last publication date:

2023-11-02

Top Assignees for applications by Mark E. Gurney

The entities that hold a legal rights for patent applications filed by inventor Gurney Mark E.:

deCODE Genetics ehf. 21 Reykjavik, Iceland
TETRA DISCOVERY PARTNERS LLC 8 Grand Rapids, MI United States
Pharmacia & Upjohn Company 7 Kalamazoo, MI United States
DECODE CHEMISTRY, INC. 4 Woodridge, IL United States
FAMILIES OF SPINAL MUSCULAR ATROPHY 3 Libertyville, IL United States
deCODE genetics ehf 3 , Iceland
ELAN PHARMACEUTICALS, INC. 3 South San Francisco, CA United States
TETRA DISCOVERY PARTNERS, INC. 2 Grand Rapids, MI United States
deCODE Genetics, Inc. 1 Reykjavik, Iceland
Tetra Discovery Partners 1 Grand Rapids, MI United States
Pharmacia & Upjohn Company, a Delaware corporation 1 Kalamazoo, MI United States
DECODE GENETICS INC. 1 Woodridge, IL United States
deCODE Genetics, Inc. 1 Reykjavik, Ireland
Families of Spinal Muscular Atrophy 1 Elk Grove Village, IL United States
University of Miami 1 Miami, FL United States
DECODE CHEMISTRY, INC. 1 Naperville, IL United States
DeCODE Genetics enf 1 Reykjavik, Iceland
PHARMACIA & UPJOHN CO. 1 Portage, MI United States

Recent patent applications by Gurney Mark E.

Mark E. Gurney from Grand Rapids, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-02

US20230348501A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#2 | 2023-01-26

US20230024240A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#3 | 2020-11-12

US20200354384A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#4 | 2020-10-29

US20200339532A1

Chemistry; metallurgy

PDE4D inhibitors

#5 | 2020-10-22

US20200331858A1

Chemistry; metallurgy

Salts and polymorphs of a PDE4 inhibitor

#6 | 2019-09-05

US20190270759A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#7 | 2019-02-21

US20190055269A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#8 | 2017-11-30

US20170342094A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#9 | 2016-06-02

US20160152577A1

Chemistry; metallurgy

2,4-Diaminoquinazolines for Spinal Muscular Atrophy

#10 | 2016-05-19

US20160137672A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#11 | 2015-04-30

US20150119362A1

Chemistry; metallurgy

Heteroaryl inhibitors of PDE4

#12 | 2014-10-09

US20140301999A1

Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#13 | 2014-09-18

US20140275553A1

Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#14 | 2014-05-01

US20140121221A1

Chemistry; metallurgy

Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

#15 | 2012-08-23

US20120213758A1

Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#16 | 2012-08-16

US20120207729A1

Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#17 | 2012-07-19

US20120183522A1

Chemistry; metallurgy

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#18 | 2011-12-01

US20110294149A1

Chemistry; metallurgy

Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor

#19 | 2011-05-12

US20110112118A1

Chemistry; metallurgy

2,4-Diaminoquinazolines for spinal muscular atrophy

#20 | 2011-02-15

US10801509

Substrates and assays for β-secretase

#21 | 2010-09-28

US10801487

Substrates and assays for β-secretase

#22 | 2010-08-26

US20100216863A1

Human necessities

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

#23 | 2009-12-31

US20090324569A1

Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#24 | 2009-11-26

US20090291948A1

Chemistry; metallurgy

SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE

#25 | 2009-09-17

US20090233969A1

Chemistry; metallurgy

BIARYL SUBSTITUTED NITROGEN CONTAINING HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION

#26 | 2009-05-28

US20090136473A1

Chemistry; metallurgy

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#27 | 2009-05-21

US20090131530A1

Chemistry; metallurgy

4-(or 5-) substituted catechol derivatives

#28 | 2009-05-21

US20090130077A1

Chemistry; metallurgy

Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#29 | 2009-05-21

US20090130076A1

Chemistry; metallurgy

SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#30 | 2009-03-19

US20090075316A1

Chemistry; metallurgy

Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor

#31 | 2009-02-12

US20090042900A1

Chemistry; metallurgy

2,4-diaminoquinazolines for spinal muscular atrophy

#32 | 2009-01-29

US20090030037A1

Human necessities

Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy

#33 | 2008-12-04

US20080299596A1

Chemistry; metallurgy

Substrates and assays for beta-secretase activity

#34 | 2008-11-27

US20080293750A1

Chemistry; metallurgy

Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment

#35 | 2008-05-27

US10652045

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

#36 | 2008-05-20

US10652830

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

#37 | 2008-05-06

US10652927

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

#38 | 2008-04-17

US20080090839A1

Chemistry; metallurgy

Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation

#39 | 2008-02-07

US20080033024A1

Chemistry; metallurgy

Aryl amino acid derivatives as inhibitors for treating inflammation

#40 | 2008-02-07

US20080033013A1

Chemistry; metallurgy

Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation

#41 | 2007-12-06

US20070280917A1

Chemistry; metallurgy

Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype

#42 | 2007-06-28

US20070149544A1

Chemistry; metallurgy

Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation

#43 | 2007-06-21

US20070142434A1

Chemistry; metallurgy

N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation

#44 | 2007-06-21

US20070142432A1

Chemistry; metallurgy

Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation

#45 | 2007-04-17

US9908943

Substrates and assays for β-secretase activity

#46 | 2006-11-16

US20060257481A1

Human necessities

Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy

#47 | 2006-05-09

US9548370

Alzheimer's disease secretase, APP substrates therefor, and uses thereof

#48 | 2006-04-13

US20060079520A1

Chemistry; metallurgy

Sulfonamide peri-substituted bicyclics for occlusive artery disease

#49 | 2006-02-09

US20060029546A1

Human necessities

Materials and methods for identifying anti-schizophrenic agents

#50 | 2006-01-26

US20060019269A1

Human necessities

Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment

#51 | 2005-12-29

US20050288314A1

Chemistry; metallurgy

2,4-diaminoquinazolines for spinal muscular atrophy

#52 | 2005-07-05

US9794743

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

#53 | 2005-05-05

US20050096457A1

Chemistry; metallurgy

Substrates and assays for beta-secretase

#54 | 2005-04-14

US20050080232A1

Chemistry; metallurgy

Alzheimer's disease secretase, app substrates therefor, and uses therefor

#55 | 2005-03-15

US9548365

Alzheimer's disease secretase, APP substrates therefor, and uses thereof

InventorID:

746355 ⎘